Trial intelligence / Profile preview

Effect of ADRB2 Polymorphism on Asthma Control with LABA in Children

NCT01108627Phase 4Withdrawn

Sponsor
Nemours Children's Health
Start
Oct 2010
Primary completion
Dec 2011
Modality
Small Molecules
01

Overview

A Phase 4 trial of formoterol in asthma, sponsored by Nemours Children's Health. Planned start Oct 2010; status: withdrawn.

02

Drugs

formoterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01108627.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01108627.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call